A physically meaningful relationship between R50% and PTV surface area in lung SBRT
Authors:
Open Access
- 28 July 2020
- journal article
- research article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (9) , 47-56
Abstract
Purpose: We propose a novel understanding of two characteristics of the planning target volume (PTV) that affect the intermediate‐dose spill in lung stereotactic body radiation therapy (SBRT) as measured by R50%. This phantom model research investigates two characteristics of the PTV that have a marked effect on the value of R50%: the mean dose deposited within the PTV (Dav) and the surface area of the PTV (SAPTV).Methods: Using a phantom model provided by a CT of the IROC Thorax‐Lung Phantom® (IROC Houston QA Center, Houston, TX) and Eclipse® Treatment Planning System (Varian Medical Systems, Palo Alto, CA), we investigate the two characteristics for spherical and cylindrical PTVs. A total of 135 plans with tightly controlled PTV characteristics are employed. A lower bound for R50% (R50%min∆r) is derived and clearly establishes a relationship between R50% and SAPTV that has not been fully appreciated previously.Results: The study of PTV Dav revealed a local minimum for R50% as a function of the PTV Dav at Dav ≈ 110% of Rx dose. As PTV Dav increases above this local minimum, R50% increases; while for PTV Dav less than this local minimum, the R50% value also increases. The study of PTV surface area (SAPTV) demonstrated that as the SAPTV increases, the R50% increases if the PTV volume stays the same. The SAPTV result is predicted by the theoretical investigation that yields the R50% lower bound, R50%min∆r.Conclusions: This research has identified two characteristics of the PTV that have a marked influence on R50%: PTV Dav and SAPTV. These characteristics have not been clearly articulated in the vast body of previous research in SBRT. These results could help explain plans that cannot meet the RTOG criteria for R50%. With further development, these concepts could be extended to provide additional guidance for creating acceptable SBRT plans.Keywords
This publication has 25 references indexed in Scilit:
- Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical PracticeJournal of Clinical Oncology, 2014
- Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohortRadiotherapy and Oncology, 2013
- Definition of stereotactic body radiotherapyStrahlentherapie und Onkologie, 2013
- Consideration of optimal isodose surface selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: comparison of 90%, 80% and 70% isodose surface-based planningBritish Journal of Radiology, 2012
- Generalizable Class Solutions for Treatment Planning of Spinal Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Experience of micromultileaf collimator linear accelerator based single fraction stereotactic radiosurgery: Tumor dose inhomogeneity, conformity, and dose fall offMedical Physics, 2011
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Red Shell: Defining a High-Risk Zone of Normal Tissue Damage in Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyRadiation Oncology, 2009